Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03727009 · ClinicalTrials.gov registry record
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
A clinical trial, sponsored by Exact Sciences Corporation.
- Terminated
- Registry status
- 409
- Enrollment target
NCT03727009 is a clinical trial that was terminated before completion, run by Exact Sciences Corporation. The registered enrollment target is 409 participants.
The verdict
NCT03727009 was terminated before completion, sponsored by Exact Sciences Corporation.
- TERMINATED
- Registry status
- 409 participants
- Enrollment target
Study Summary
The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.
Interventions
- OTHER Blood Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 409 participants |
| Start Date | 2018-12-07 |
| Est. Completion | 2020-03-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03727009
The ClinicalTrials.gov registry entry for NCT03727009 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 409 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Sample Collection is the first listed.
NCT03727009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03727009 about?
NCT03727009 is a clinical study titled "Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies". The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.
What is the current status of trial NCT03727009?
This trial is currently terminated. The enrollment target is 409 participants. The study started on 2018-12-07. Estimated completion is 2020-03-24.
What interventions are being tested in trial NCT03727009?
The interventions under investigation include: Blood Sample Collection (OTHER).
Who is sponsoring clinical trial NCT03727009?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.